![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 12976 | Ordered by Person (ascending)
1 2 3 ... 128 129 130 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| à Brassard, Lothar (Chemagen 201102 CEO) | Chief Executive Officer (CEO) | PerkinElmer (Group) | Germany |
| Aabo, Gitte (Leo Pharma 201511 CEO) | Chief Executive Officer (CEO) | Leo Pharma (Group) | Denmark |
| Aamund, Asger (Bavarian Nordic 200804 Chairman) | n. a. | Bavarian Nordic (Group) | Denmark |
| Aanur, Praveen (Moderna 202310 VP Oncology Therapeutic Area Head) | President/Director/Head Business Group/Unit/Division | Moderna (Group) | United States (USA) |
| Aasen, Thomas H. (Acadia 200409) | n. a. | Acadia (Group) | United States (USA) |
| Abastado, Jean-Pierre (Servier 201507 Director Oncology Innovation Therapeutic Pole) | Research & Development Manager | Servier (Group) | France |
| Abate, Emmanuel (Danaher 202210 President Genomic Medicine at Cytiva) | President/Director/Head Business Group/Unit/Division | Danaher (Group) | United Kingdom (GB) |
| Abbassi, Kayla (VSC (US) 202005 Senior Account Manager) | Public Relations Manager / Investor Relations Manager | VSC (US) | United States (USA) |
| Abbey, Jeffrey (Jeff) (ImmunOs Therapeutics 202109– COO before Independent Consultant + Novadip Biosciences + Argos Tx) | Chief Operating Officer (COO) | ImmunOs Therapeutics AG | Switzerland |
| Abbott, Mark (Peak Proteins 202204 CEO) | Chief Executive Officer (CEO) | Sygnature Discovery (Group) | United Kingdom (GB) |
| Abdollahian, Neil (Boundless Bio 202108– CBO before Cidara Therapeutics + Clarity Point Partners + Trius Therapeutics) | Chief Business Officer (CBO) | Boundless Bio Inc. | United States (USA) |
| Abdun-Nabi, Daniel (Emergent BioSolutions 200806 President + COO) | Chief Operating Officer (COO) | Emergent BioSolutions (Group) | United States (USA) |
| Abecassis, William (BlackRock 202103 Head of Innovation Capital) | Investment Manager | BlackRock (Group) | United States (USA) |
| Abel, Stan E. (Corthera 200712– CEO before Cerexa Inc CFO + co-founder before Peninsula Pharma CFO before Lilly) | Chief Executive Officer (CEO) | Novartis (Group) | United States (USA) |
| Abeliovich, Asa (Prevail Therapeutics 202012 CEO + Founder) | Chief Executive Officer (CEO) | Eli Lilly (Group) | United States (USA) |
| Abend, Sven (Lonza 201903– COO of Lonza Specialty Ingredients segment) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Switzerland |
| Abercrombie, George (Roche US 200609 President + CEO) | Chief Executive Officer (CEO) | Roche (Group) | United States (USA) |
| Aberman, Zami (Pluristem 201404 CEO) | Chief Executive Officer (CEO) | Pluristem (Group) | Israel |
| Abernethy, Amy (Alphabet 202108 President of Clinical Research at Verily before Principa Deputy Commissioner of FDA) | n. a. | Alphabet (formerly Google) (Group) | United States (USA) |
| Abery, Julian (BioCity (GB) 201909– Director Business Development North America at BioAscent Discovery) | Business Development Manager / Strategy Manager | Pioneer Group, The (WAPG) (Group) | United Kingdom (GB) |
| Abi-Saab, Walid (Galapagos 201809 CMO) | Chief Medical Officer (CMO) | Galapagos (Group) | Belgium |
| Abia, Nacho (Grifols 202407 CEO) | Chief Executive Officer (CEO) | Grifols (Group) | Spain (España) |
| Abitorabi, Abi (Girus Life Sciences 200710 CEO) | Chief Executive Officer (CEO) | Girus Life Sciences Inc. | United States (USA) |
| Abken, Hinrich (Univ Cologne 201507 Prof at CMMC) | Professor | University of Cologne (Universität zu Köln) | Germany |
| Abraham, Robert (Pfizer 201412 SVP + CSO at Onology Research Unit) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Pfizer (Group) | United States (USA) |
| Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) | Chief Medical Officer (CMO) | Editas Medicine Inc. (Nasdaq: EDIT) | United States (USA) |
| Abribat, Thierry (Alizé Pharma 2007– President + Founder) | Chief Executive Officer (CEO) | Alizé Pharma (Group) | France |
| Acciarito, Tony (Thermo Fisher 201609 VP + General Manager Thermo Fisher South Korea) | General Manager (management) | Thermo Fisher (Group) | Korea, Republic of |
| Acharya, Mukta (Tecan 202408– promoted to Head of Life Sciences Business joined 7/22 before Thermo Fisher + CVS Health) | President/Director/Head Business Group/Unit/Division | Tecan (Group) | Switzerland |
| Ackerman, Samuel K. (Panacos 200508 CEO) | Chief Executive Officer (CEO) | Panacos Pharmaceuticals Inc. (Nasdaq: PANC) | United States (USA) |
| Ackermann, Niels (BioXell 200704– CFO before Morgan Stanley London + CFO of two German biotech companies) | Chief Financial Officer (CFO) | Cosmo Pharmaceuticals (Group) | Italy |
| Acosta, Colleen (Freya Biosciences 20231212 CEO + Co-Founder) | Chief Executive Officer (CEO) | Freya Biosciences ApS | Denmark |
| Adachi, Tamotsu (Carlyle Group Japan 200508) | n. a. | Carlyle (Group) | United States (USA) |
| Adachi, Yoroku (Canon USA 200504– President + CEO) | Chief Executive Officer (CEO) | Canon (Group) | United States (USA) |
| Adair, Fiona (Haptogen 200507– before Biovation + CXR Biosciences) | n. a. | Pfizer (Group) | United Kingdom (GB) |
| Adam, George F. (Rick) (Recondo Technology –200711–200811– Member of the Board of Directors) | Board member | Recondo Technology Inc. | United States (USA) |
| Adam, Maxine (United Kingdom (govt) 202310 Head of Business Growth at Innovate UK) | Business Development Manager / Strategy Manager | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Adamis, Anthony P. (Jerini Ophthalmic 200703– CEO) | Chief Executive Officer (CEO) | Takeda (Group) | United States (USA) |
| Adams, Adrian (Auxilium 201112– CEO before Neurologix + Inspire Pharma + Sepracor + Kos + Novartis UK) | Chief Executive Officer (CEO) | Dainippon Sumitomo (Group) | United States (USA) |
| Adams, Andrew (Eli Lilly 202104 VP of New Therapeutics Modalities) | Business Development Manager / Strategy Manager | Eli Lilly (Group) | United States (USA) |
| Adams, Christoph M. (FoldRx 200509– CBO before ViaCell Senior VP BusDev) | Chief Business Officer (CBO) | FoldRx Pharmaceuticals Inc. | United States (USA) |
| Adams, George (Amorfix 200601 CEO) | Chief Executive Officer (CEO) | Amorfix Life Sciences Ltd. (TSX-V: AMF) | Canada |
| Adams, Jan (Apollo Health Ventures 202109– Venture Partner before Merck KGaA + EMBL Ventures) | Venture Partner | Apollo Health Ventures (Group) | Germany |
| Adams, Julian (Gamida Cell 201906 CEO) | Chief Executive Officer (CEO) | Gamida Cell Ltd. (Nasdaq: GMDA) | Israel |
| Adams, Terry (Shimadzu 201406 VP Marketing at SSI) | Sales Manager / Marketing Manager | Shimadzu (Group) | United States (USA) |
| Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) | Chief Financial Officer (CFO) | ObsEva (Group) | Switzerland |
| Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) | Chief Executive Officer (CEO) | Pairwise (Group) | United States (USA) |
| Adcock, Richard (ImmunityBio 202401 CEO) | Chief Executive Officer (CEO) | ImmunityBio, Inc. (Nasdaq: IBRX) | United States (USA) |
| Adelhelm, Karin (Clondiag 200502) | n. a. | Abbott (Group) | Germany |
| Adelman, Burt (Dyax 2012–2016 EVP + CMO before Eleven Biotherapeutics + Biogen) | Board member, non-executive | Takeda (Group) | United States (USA) |
| Adelman, Daniel (Aimmune Therapeutics 201903 CMO) | Chief Medical Officer (CMO) | Nestlé (Group) | United States (USA) |
| Adelman, Robert (venBio 201204 Partner before OrbiMed Advisors + founder of Operon Technologies + Roka Bioscience) | Partner (venture partner) | VenBio (Group) | United States (USA) |
| Adelson, Robert (Osage Partners 201903 Managing Partner at Osage Univ Partners) | Managing Partner (investment firm) | Osage Partners (Group) | United States (USA) |
| Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) | Chief Executive Officer (CEO) | Sebia (Group) | France |
| Adewoye, Henry (Compugen 201803– CMO before Gilead Sciences + Amgen) | Chief Medical Officer (CMO) | Compugen (Group) | Israel |
| Adiri, Yonatan (Healthy.io 201909 CEO + Founder) | Chief Executive Officer (CEO) | Healthy.io Ltd. | Israel |
| Adkin, Gregg (Dell 201705 VP + Managing Director of Dell Technologies Capital) | Managing Director | Dell (Group) | |
| Adkins, John (Sterilin 200806 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | United Kingdom (GB) |
| Adomakah, Nicholas (Novartis 202301 Sandoz Anti-infectives Global Medical Lead) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Germany |
| Adulamy, Maya (Valo Health 202012– Head of Strategic Partnerships based in Israel before at Maccabi) | Business Development Manager / Strategy Manager | Valo Health (Group) | United States (USA) |
| Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) | Professor | ETH Zürich (ETHZ) | Switzerland |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) | Chief Executive Officer (CEO) | Flagship Pioneering | United States (USA) |
| Affagard, Hervé (MaaT Pharma 201507 CEO) | Chief Executive Officer (CEO) | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | France |
| Afflerbach, Henning (Coral BioNet 201205 CBO at Scil Proteins) | Chief Business Officer (CBO) | UV-Cap (Vetter family office) (Group) | Germany |
| Afonso, Carlos (Univ Rouen 201606) | Laboratory Manager (industry) | University of Rouen (Université de Rouen) | France |
| Afshar, Mohammad (Ariana Pharmaceuticals 2002– CEO + Founder) | Chief Executive Officer (CEO) | Ariana Pharmaceuticals (Group) | France |
| Afzelius, Lovisa (Flagship Pioneering 202004 existent Origination Partner former SVP of Cogen Therapeutics) | Partner (venture partner) | Flagship Pioneering | United States (USA) |
| Agarwal, Amit | n. a. | Reliant AI (Group) | Canada |
| Agarwala, Sandip (Blue Owl Capital 202208 Managing Director at Owl Rock) | Managing Director | Blue Owl Capital (Group) | United States (USA) |
| Agarwala, Vineeta (Andreessen Horowitz 202102 General Partner) | General Partner (venture partner) | Andreessen Horowitz (a16z) | United States (USA) |
| Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) | n. a. | Aureon Laboratories Inc. | United States (USA) |
| Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) | Managing Partner (investment firm) | Lundbeck (Group) | Denmark |
| Aghazadeh, Behzad (Avoro Capital 202103 Managing Partner before venBio + Sio Capital + AllianceBernstein + Booz Allen) | Managing Partner (investment firm) | Avoro Capital (Group) | United States (USA) |
| Agnus, Jean-Baptiste (JB) (JSR Corp 202404– CBO at KBI Biopharma before AGC Biologics + Ajinomoto Bio-Pharma + Novasep) | Chief Business Officer (CBO) | JSR Corporation (Group) | United States (USA) |
| Agrawal, Nitin (Texas A&M Univ 200705 Chemical Engineering) | n. a. | Texas A&M University System (TAMU) | United States (USA) |
| Agrawal, Sudhir (Hybridon 200506 CEO + CSO) | Chief Executive Officer (CEO) | Idera Pharmaceuticals Inc. (Nasdaq: IDRA) | United States (USA) |
| Agrawal, Sudhir (Idera 200612 CEO + CSO) | Chief Executive Officer (CEO) | Idera Pharmaceuticals Inc. (Nasdaq: IDRA) | United States (USA) |
| Agrawal, Sundeep (Colt Ventures 202211 General Partner) | General Partner (venture partner) | Colt Ventures (family office of Darren Blanton) | United States (USA) |
| Aguiar, Michael (Theravance 200601 Senior VP + CFO) | Chief Financial Officer (CFO) | Innoviva (Group) | United States (USA) |
| Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) | Chief Operating Officer (COO) | ||
| Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) | Chief Executive Officer (CEO) | Asahi Kasei (Group) | Sweden |
| Agus, David (Ellison Institute for Transformative Medicine 202205 Co-Founder) | Company Founder | Lawrence J. Ellison Institute for Transformative Medicine | United States (USA) |
| Ahanola, Jani (Noona Healthcare 201611 CEO) | Chief Executive Officer (CEO) | Noona Healthcare (FI) | Finland |
| Ahlberg, Christopher (Spotfire 200505 CEO) | Chief Executive Officer (CEO) | TIBCO Software (Group) | United States (USA) |
| Ahmad, Shidah (Agilent 201204 VP + General Manager) | General Manager (management) | Agilent (Group) | United States (USA) |
| Ahmadi, Khatereh (Merck (US) 201810 Executive Director Business Development + Licensing) | Business Development Manager / Strategy Manager | Merck (US) (MSD) (Group) | United States (USA) |
| Ahmed, Nadim (BMS 202109 EVP) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
| Ahrens, Brent (Canaan Partners 201603 General Partner) | General Partner (venture partner) | Canaan Partners (Group) | United States (USA) |
| Ahuja, Parmeet (Agilent 201103 Country General Manager India) | Regional manager | Agilent Technologies Inc. (NYSE: A) | India |
| Aiach-Pignet, Karen (Genespire 202409– CEO before Lysogene CEO + Founder) | Chief Executive Officer (CEO) | Genespire S.r.l. | Italy |
| Aiguabella Font, Nuria (Bayer 202108 Global Communications Bayer Pharma New Modalities) | Public Relations Manager / Investor Relations Manager | Bayer (Group) | Germany |
| Ainsworth, Kristin (Seres Therapeutics 202105 Public Relationns) | Public Relations Manager / Investor Relations Manager | Seres Therapeutics Inc. (Nasdaq: MCRB) | United States (USA) |
| Ainsworth, Sean (Immusoft 201801– CEO before Allergan + RetroSense Therapeutics) | Chief Executive Officer (CEO) | Immusoft Corporation | United States (USA) |
| Aithani, Lakshyaditya Singh (Laksh) (Charm Therapeutics 202206 CEO + Co-Founder before Braavos + Exscientia + genei) | Chief Executive Officer (CEO) | Charm Therapeutics Ltd. | United Kingdom (GB) |
| Aitkenhead, Mark (Element Biosciences 202205– Chief Commercial Officer before at Thermo Fisher since 2003) | Chief Commercial Officer (CCO) | Element Biosciences Inc. | United States (USA) |
| Ajani, Mauro Severino (Cosmo Pharmaceuticals 202404 Board Director) | Board member, non-executive | Cosmo Pharmaceuticals (Group) | Ireland, Republic of |
| Akerman, Martin (Envisagenics 202211 CTO + Co-Founder) | Chief Technology/Technical Officer (CTO) | Envisagenics Inc. | United States (USA) |
| Akhlagi, Fatemah (Univ Rhode Island 201007 Assoc Prof Pharmacokinetics at School of Pharmacy) | Assistant Professor / Associate Professor | University of Rhode Island | United States (USA) |
| Akhmedov, Murodzhon (BigOmics 202203 CEO + Co-Founder) | Chief Executive Officer (CEO) | BigOmics Analytics S.A. | Switzerland |
| Akin, Tom (CombiMatrix 201004 Board Chairman) | Board member, non-executive | Invitae (Group) | United States (USA) |
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px](/banner/iito-business-intelligence-20220406-650-200-lse-life-sciences-europe.jpg)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
